Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

A person who has the type of anemia with B12 deficiency and low B12 levels (called "megaloblastic anemia" with unusual white ...

Most of us take aspects of our everyday lives for granted, like the ability to easily speak or eat.But for four million Americans with Sjögren's syndrome -- a disease that causes ...

Bacteria in the gut have been implicated in autoimmune diseases, like lupus, that don't primarily affect the gastrointestinal ...

Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system—a group of proteins that ...

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

Patients with Klinefelter and triple X syndromes show an increased prevalence of SLE and Sjögren disease, likely due to the ...

Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.